Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

H. Lundbeck A Director's Dealing 2016

Aug 25, 2016

3367_rns_2016-08-25_89502315-38fe-4bee-83d0-b0742aaf2d2c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

H. Lundbeck A/S

Ottilavej 9

DK-2500 Valby, Copenhagen

CVR number: 56759913

Tel +45 36 30 13 11

Fax +45 36 43 82 62

E-mail [email protected]

www.lundbeck.com

Lundbeck

Correction of Corporate Release No. 595 - Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 25 August 2016 – H. Lundbeck A/S (Lundbeck) hereby corrects Company Release no. 595. The correct buyer of shares in Lundbeck is Lene Skole-Sørensen. The correction is set out in item 2.b) of the last schedule below.

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Anders Götzsche
2. Reason for the notification
a) Position/status Executive Vice President & CFO
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: H. Lundbeck A/S
b) LEI-kode Not required
4.A. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Warrant
DK 0010287234
b) Nature of the transaction Other transaction (exercise of warrants)
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 126.66 42,478
DKK 121.79 28,318
d) Aggregated information
— Aggregated volume
— Price 70,796
124.712
e) Date of the transaction 2016-08-25
f) Place of the transaction H. Lundbeck A/S (the subscribed for shares will be registered on

25 August 2016

Corporate Release No 596


Lundbeck

transaction NASDAQ Copenhagen XCSE)
4.B Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Share
Identification code DK 0010287234
b) Nature of the transaction Sale of share
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 274.2186 80,361
d) Aggregated information - Aggregated volume - Price
e) Date of the transaction 2016-08-25
f) Place of the transaction NASDAQ Copenhagen XCSE
1. Details of the person discharging managerial responsibilities/person closely associated
--- --- ---
a) Name Lene Skole-Sørensen (corrected from Anders Tormod Skole-Sørensen)
2. Reason for the notification
a) Position/status Deputy-chairman of the Board of Directors.
b) Initial notification/ Amendment Amendment. The notification in Company Release no. 595 mistakenly stated that Anders Tormod Skole-Sørensen had purchased shares in Lundbeck. The shares were purchased by Lene Skole-Sørensen. This form is amended in accordance herewith.
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: H. Lundbeck A/S
b) LEI-code Not required

25 August 2016

Corporate Release No 596


Lundbeck

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Share DK 0010287234
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
272.000 917
272.600 915
d) Aggregated information - Aggregated volume - Price 1,832 272.299
e) Date of the transaction 2016-08-25
f) Place of the transaction Nasdaq Copenhagen XCSE

Persons under an obligation to report are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

  • spouse or cohabitant
  • dependent children
  • legal entities in which the executive has a controlling influence.

25 August 2016

Corporate Release No 596


Lundbeck

Lundbeck contacts

Investors:
Palle Holm Olesen
Vice President, Investor Relations
[email protected]
+45 30 83 24 26

Media:
Mads Kronborg
Senior Director, Corp. Communication
[email protected]
+45 36 43 40 00

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are depression, schizophrenia, Parkinson's disease and Alzheimer's disease.

An estimated 700 million people worldwide are living with psychiatric and neurological disorders and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with psychiatric and neurological disorders – we call this Progress in Mind.

Our approximately 5,000 employees in 55 countries are engaged in the entire value chain throughout research, development, manufacturing, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. We have research centres in China and Denmark and production facilities in China, Denmark, France and Italy. Lundbeck generated revenue of DKK 14.6 billion in 2015 (EUR 2 billion; USD 2.2 billion).

For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck.

25 August 2016
Corporate Release No 596
page 4 of 4